- From Pharmacogenomics to Improved Patient Outcomes: Angiotensin I-Converting Enzyme as an Example
- Is Angiotensin I-Converting Enzyme a “Master” Disease Gene?
- Is “Somatic” Angiotensin I-Converting Enzyme a Mechanosensor?
- Pathophysiologic Implications of Angiotensin I-Converting Enzyme as a Mechanosensor: Diabetes
- Why AT1R blockade makes sense for SARS
- The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology
- Written evidence included in July 7, 2009 report on genomic medicine by the British House of Lords (view report)
- Are Blockbuster Drugs Still Possible in the Era of Personalized Medicine?
- A Modern-Day Tuskegee… and What’s Really Wrong with U.S. Health Care Today?
- Precision Medicine — Too Much Precision, Not Enough Medicine?
- Quercetin for Covid19?